Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
European Innovation Council
BioCentury | Feb 6, 2025
Finance
European start-ups Akribion, Aplagon each draw funding: Venture Report
German biotech Akribion advancing nucleases for programmable cell depletion; Finland’s Aplagon developing vascular treatment
BioCentury | Jun 21, 2024
Finance
Venture Report: Syncona’s backs a pair of biotechs; Marea makes debut with $190M
Plus: Forbion’s new sustainability fund, and rounds for Elion, ashibio, NephroDI and Ability
BioCentury | Dec 13, 2023
Finance
Dec. 12 Quick Takes: Targeted genomic DNA insertion company Tome launches with $213M
Plus: Bicara’s latest big round is a $165M series C, Shinobi launches, Pfizer readies to close Seagen deal and more
BioCentury | Oct 11, 2023
Deals
Oct. 10 Quick Takes: Sanofi strikes another AI partnership via BioMap biologics design deal
Plus: With restructuring, Sana to focus on
BioCentury | Jun 27, 2023
Product Development
June 27 Quick Takes: FDA denies Regeneron’s high-dose Eylea
Plus: Sanofi meets in atopic dermatitis and updates from Nkarta, Astraveus and more
BioCentury | May 26, 2023
Finance
May 25 Quick Takes: VarmX is latest biotech to extend series B
Plus: Apellis/Sobi candidate misses in ALS and updates from Annexon, Pfizer and more
BioCentury | May 25, 2023
Management Tracks
Alvin Luk named CEO of HuidaGene
Plus:TScan’s MacBeath now permanent CEO; chair, CMO, seed money for InProTher
BioCentury | May 4, 2023
Finance
May 3 Quick Takes: Clinical-stage targeted radio-antibody newco Convergent raises $90M A round
Plus: Big gain for ImmunoGen as Elahere hits mark in confirmatory study and updates from Cowen, Longwood, Morphic, Arthex and Dianthus
BioCentury | Oct 21, 2022
Politics, Policy & Law
Oct. 20 Quick Takes: Novartis commits first cancer therapy to UN patent pool
Plus: AbbVie gains LPAR1 antibody via $255M buy of DJS and updates for Denali, the U.K., Kite-Refuge, Takeda-Zedira, Immunic, Talaris, Celeris
BioCentury | Jun 25, 2022
Regulation
June 24 Quick Takes: Innovent, Lilly gain China label expansion in gastric cancer
Plus GSK, Sanofi report COVID-19 booster vaccine efficacy, and updates from Cytokinetics, Novartis, Idoven and more
Items per page:
1 - 10 of 13